A discovery program for SARS-CoV-2-nABs potentially targeting its resistant strains.
RNA Therapeutics Core launches at Mass General Brigham to boost circular RNA research
The Mass General Brigham Gene and Cell Therapy Institute (GCTI) today announced it has launched the RNA Therapeutics Core, a first-of-its-kind, state-of-the-art facility and resource